Editorial office, European Journal of Clinical Oncology, UK
Perspective
Carbon-ion radiotherapy for non-small cell lung cancer
Author(s): Cole Shelton*
Carbon-Ion Radiation (CIRT) is a critical component of contemporary radiotherapy. CIRT has two key benefits over traditional photon radiation modalities in terms of physical and biological considerations. Physical benefits include increased dose distribution to the tumoral region and reduced dose harm to adjacent tissue. The biological benefits include an increase in Double-Strand Breaks (DSBs) in DNA structures, an increase in oxygen enhancement ratio, and improved radiosensitivity as compared to X-ray radiation. CIRT has two advantages: it not only inflicts severe cytotoxic damage on tumor cells, but it also protects adjacent tissue. Lung cancer is the second most frequent cancer in the world, after breast cancer, in terms of annual diagnosis. Lung cancer, on the other hand, is the primary cause of cancer death. Patients with stage I non-small cell lung cancer (NSCLC) who were treat.. View More»
DOI:
10.35248/clinical-oncology. 4(5).59-60.
